St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: A single-center randomized open-label trial (St. John's Trial)

Journal of Cardiovascular Translational Research

Volumn 6, Issue 3, 2013, Pages 411-414

  Trana, Catalina ^a   Toth, Gabor ^a   Wijns, William ^a   Barbato, Emanuele ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

Clopidogrel; Non response; Platelet reactivity; St. John's Wort

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYPERICUM PERFORATUM EXTRACT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DISTRIBUTION; DYSLIPIDEMIA; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LOADING DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; STABLE ANGINA PECTORIS; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

AGED; ANALYSIS OF VARIANCE; BELGIUM; BLOOD PLATELETS; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

ANGINA;

EID: 84877763613     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9455-2     Document Type: Article

References (12)

1. Lau, C. W., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G., et al. (2004). Contribution of cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation, 109, 166-171.
2. Patti, G., Nusca, A., Mangiacapra, F., Gatto, L., D'Ambrosio, A., & Di Sciacio, G. (2008). Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention. Journal of the American College of Cardiology, 52, 1128-1133.
3. Daemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., et al. (2007). Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet, 369, 667-678.
4. Mangiacapra, F., De Bruyne, B., Muller, O., Trana, C., Ntalianis, A., Bartunek, J., et al. (2010). High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention. Journal of the American College of Cardiology Interventions, 3, 35-40.
5. Roby, C. A., Anderson, G. D., Kantor, E., Dryer, D. A., & Burstein, A. H. (2000). St. John's Wort: effect on CYP3A4 activity. Clinical Pharmacology and Therapeutics, 67, 451-457.
6. Lau, W. C., Welch, T. D., Shields, T., Rubenfire, M., Tantry, U. S., & Gurbel, P. A. (2011). The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. Journal of Cardiovascular Pharmacology, 57, 86-93.
7. Barbato, E., Piscione, F., Bartunek, J., Galasso, G., Cirillo, P., De Luca, G., et al. (2005). Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation, 111, 288-294.
8. Mangiacapra, F., Bartunek, J., Bijnens, N., Peace, A. J., Dierickx, K., Bailleul, E., et al. (2012). Peri-procedural variations of platelet reactivity during elective percutaneous coronary intervention. Journal of Thrombosis and Haemostasis, 10, 2452-2461.
9. Campo, G., Parrinello, G., Ferraresi, P., Lunghi, B., Tebaldi, M., Miccoli, M., et al. (2011). Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. Journal of the American College of Cardiology, 57, 2474-2483.
10. Collet, J. P., Silvain, J., Landivier, A., Tanguy, M. L., Cayla, G., Bellemain, A., et al. (2008). Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the reload with clopidogrel before coronary angioplasty in subjects treated long term with dual antiplatelet therapy (RELOAD) study. Circulation, 118, 1225-1233.
11. Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 357, 2001-2015.
12. Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 361, 1045-1057.